1. Home
  2. WT vs WGS Comparison

WT vs WGS Comparison

Compare WT & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WisdomTree Inc.

WT

WisdomTree Inc.

HOLD

Current Price

$13.88

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$57.52

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WT
WGS
Founded
1985
2017
Country
United States
United States
Employees
N/A
1300
Industry
Investment Bankers/Brokers/Service
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
WT
WGS
Price
$13.88
$57.52
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$16.75
$140.71
AVG Volume (30 Days)
2.2M
679.7K
Earning Date
05-01-2026
04-29-2026
Dividend Yield
0.82%
N/A
EPS Growth
127.27
N/A
EPS
0.75
N/A
Revenue
$493,753,000.00
N/A
Revenue This Year
$35.32
$29.98
Revenue Next Year
$8.08
$26.04
P/E Ratio
$19.43
$1,251.58
Revenue Growth
15.43
N/A
52 Week Low
$7.47
$55.17
52 Week High
$17.68
$170.87

Technical Indicators

Market Signals
Indicator
WT
WGS
Relative Strength Index (RSI) 38.84 27.96
Support Level $13.07 N/A
Resistance Level $14.96 $95.75
Average True Range (ATR) 0.61 4.43
MACD -0.13 -1.25
Stochastic Oscillator 17.84 5.64

Price Performance

Historical Comparison
WT
WGS

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: